David S. Snyder, MD, discusses using ruxolitinib to prevent patients receiving stem cell transplantation from developing graft versus host disease.
David S. Snyder, MD
Articles by David S. Snyder, MD
Latest Updated Articles
Ruxolitinib Used to Prevent GVHD Throughout Stem Cell TransplantationSeptember 12th 2019